期刊文献+

降低ATM的表达促进儿童AML细胞增殖和G0/G1向S/G2期细胞转化

Downregulated of ATM in pediatric AML can promote AML cell proliferation and transition from G0/G1 to S
下载PDF
导出
摘要 目的研究ATM基因在急性髓系白血病细胞(AML)中的表达对细胞增殖和细胞周期的影响。方法采用定量PCR检测儿童AML白血病细胞中ATM基因的表达情况。采用siRNA转染AML白血病细胞株NB4及K562降低ATM基因的表达。采用CCK-8计数法检测ATM基因对人AML细胞系增殖的影响,采用流式细胞术分析细胞周期情况。结果ATM基因在儿童AML白血病细胞中表达明显降低,与对照组相比差异有显著性(P<0.05)。CCK-8检测结果显示,降低ATM基因的表达可以促进白血病细胞增殖,且可以促进白血病细胞细胞周期转变,促进G0/G1期细胞向S及G2期细胞转变。结论儿童AML白血病细胞中ATM基因低表达,抑制ATM基因表达可以促进AML细胞增殖及G0/G1期细胞向S及G2期细胞转变。因此,ATM基因在AML中起"抑癌基因"作用。 Objective To investigate the expression of ATM in children with acute myeloid leukemia (AML) cells and explore its impact on proliferation and cell cycle. Methods The expression of ATM in children AML cells was detected by quantitative polymerase chain reaction (qPCR). Moreover, cell cycle and cell proliferation were evaluated in cell lines ( NB4 and K562) by using CCK-8 and flow cytometry after transfected with ATM siRNA. Results We found that ATM was significantly decreased in children AML cells, compared with that in control group ( P 〈 0.05 ). Through reducing expression of ATM in cell lines by siRNA transfection, cell proliferation was significantly enhanced and the ratio of S-phase and G2-phase cells was increased. Conclusions Downregulation of ATM in children AML cells can promote AML cell proliferation and transition from Gl-phase to S-phase. Therefore, ATM may act as a tumor suppressing gene.
作者 张晓红 颜慕霞 骆梓燕 ZHANG Xiaohong YAN muxia LUO Ziyan.(Hematology and Oncology of Pediatric,Guangzhou Women and Children Medical Center, Guangzhou 510623, China)
出处 《中国小儿血液与肿瘤杂志》 CAS 2017年第4期180-184,共5页 Journal of China Pediatric Blood and Cancer
基金 国家自然科学基金资助项目(81272310) 广东省卫生厅医学科研基金(B2010273) 广州市医药卫生科技项目(20142A011017 2009-YB-068)
关键词 ATM基因 白血病 增殖 细胞周期 ATM Leukemia Proliferation Cell cycle
  • 相关文献

参考文献1

二级参考文献12

  • 1吴雨洁,李建勇,朱光荣,宋君红,肖冰.ZAP-70在24例B细胞慢性淋巴细胞白血病中的表达研究[J].中国实验血液学杂志,2006,14(2):237-240. 被引量:16
  • 2李丽,徐卫,李建勇.慢性淋巴细胞白血病预后因素研究进展[J].中华内科杂志,2006,45(9):781-783. 被引量:17
  • 3Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 1981,48:198- 206.
  • 4Xu W, Li JY, Pan JL, et al. Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in Chinese patients with B-cell chronic lymphocytic leukemia. Int J Hematol, 2007, 85 : 430-436.
  • 5Thornton PD, Gruszka-Westwood AM, Hamoudi RA, et al. Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia. Hematol J, 2004, 5: 47-54.
  • 6Lazaridou A, Miraxtsi C, Korantzis J, et al. Simultaneous detection of BCL-2 protein, trisomy 12, retinoblastoma and P53 monoallelic gene deletions in B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization (FISH) : relation to disease status. Leuk Lymphoma, 2000, 36:503-512.
  • 7Shaw GR, Kronberger DL. TP53 deletions but not trisomy 12 are adverse in B-cell lymphoproliferative disorders. Cancer Genet Cytogenet, 2000, 119:146-154.
  • 8Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med, 2000, 343 : 1910-1916.
  • 9Stilgezbauer S, Dohner H. Molecular genetics and its clinical relevance. Hematol Oncol Clin North Am, 2004, 18: 827-848.
  • 10Osuji NC, Del Giudice I, Matutes E, et al. The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53. Haematologica, 2005, 90: 1435-1436.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部